| FWWNX | WELIX | FWWNX / WELIX | |
| Total Expense Ratio | 0.62 | 0.94 | 66% |
| Annual Report Gross Expense Ratio | 0.62 | 1.18 | 53% |
| Fund Existence | 6 years | 18 years | - |
| Gain YTD | 16.494 | 14.693 | 112% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 90B | 98.7M | 91,185% |
| Annual Yield % from dividends | 1.21 | 0.82 | 147% |
| Returns for 1 year | 17.30 | 20.60 | 84% |
| Returns for 3 years | 54.17 | 61.99 | 87% |
| Returns for 5 years | 19.50 | 3.50 | 558% |
| Returns for 10 years | N/A | 67.71 | - |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| ICTEX | 20.74 | 0.56 | +2.78% |
| ICON Health and Information Tech Instl | |||
| MGIBX | 45.07 | N/A | N/A |
| MFS International Intrinsic Equity B | |||
| FACTX | 56.71 | N/A | N/A |
| Fidelity Advisor Health Care M | |||
| GCMTX | 37.39 | N/A | N/A |
| Goldman Sachs Mid Cap Value Inv | |||
| MNHRX | 26.69 | N/A | N/A |
| Manning & Napier Pro-Blend Max Term R | |||